David J. Ecker

Ibis Biosciences develops systems for identification and characterization of infectious agents. It offers Ibis T5000 Biosensor System, a hardware platform for the identification of biological organisms including bacteria, viruses, fungi, and protozoa. The company was founded by David J. Ecker and is headquartered in Abbott Park, IL.

Lumiphore, Inc. develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. The firm offers biological detection systems based on luminescent lanthanide complexes and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics. The company was founded by Stephane Petoud and Kenneth N. Raymond in 2001 and is headquartered in Berkeley, CA.

Lumiphore, Inc. develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. The firm offers biological detection systems based on luminescent lanthanide complexes and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics. The company was founded by Stephane Petoud and Kenneth N. Raymond in 2001 and is headquartered in Berkeley, CA.

Lumiphore, Inc. develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. The firm offers biological detection systems based on luminescent lanthanide complexes and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics. The company was founded by Stephane Petoud and Kenneth N. Raymond in 2001 and is headquartered in Berkeley, CA.

Lumiphore, Inc. develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. The firm offers biological detection systems based on luminescent lanthanide complexes and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics. The company was founded by Stephane Petoud and Kenneth N. Raymond in 2001 and is headquartered in Berkeley, CA.